1. A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. (7th March 2020) Authors: Hajek, Roman; Pour, Ludek; Ozcan, Muhit; Martin Sánchez, Jesus; García Sanz, Ramon; Anagnostopoulos, Achilles; Oriol, Albert; Cascavilla, Nicola; Terjung, Andreas; Lee, Yihua; Briso, Eva M.; Dobkowska, Edyta; Hauns, Bernhard; Špička, Ivan Journal: European journal of haematology Issue: Volume 104:Number 5(2020) Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗